Cetera Investment Advisers Catalent, Inc. Transaction History

Cetera Investment Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$42.56 - $59.82 $495,313 - $696,185	11,638 New	11,638 $656,000
Q2 2022 Aug 11, 2022	BUY	$87.2 - $114.05 $5,755 - $7,527	66 Added 2.3%	2,932 $315,000
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $30,423 - $40,210	-323 Reduced 10.13%	2,866 $318,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $36,229 - $42,138	303 Added 10.5%	3,189 $408,000
Q3 2021 Nov 16, 2021	BUY	$109.17 - $142.35 $315,064 - $410,822	2,886 New	2,886 $384,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.